National quantification of HIV/AIDS program pharmaceutical needs for July 2019–June 2021

Abstract

As part of a comprehensive and effective response to HIV/AIDS, the process of securing and sustaining the continuity of pharmaceutical supplies in rapidly growing programs requires considerable financial and human resources, strong supply chain management, and close coordination. The Federal Ministry of Health, Ethiopian Pharmaceuticals Supply Agency (EPSA), Federal HIV/AIDS Prevention and Control Office (FHAPCO), Ethiopian Public Health Institute (EPHI), and partners consider the routine and comprehensive quantification of HIV/AIDS pharmaceuticals to be a critical step in implementing an effective program. To quantify health commodity demands, stakeholders considered several current developments in the HIV/AIDS prevention and control program:Revision of the national guidelines for comprehensive HIV prevention, care, and treatment; introduction of dolutegravir based regimen; NVP based regimen shift; optimization of pediatrics regimen; introduction of third-line treatment; change in test protocol; introduction of new laboratory testing equipment and pediatrics accelerated plan. The objective of the workshop was to review currently assessed data on program performance and reach consensus on the data and other key assumptions required to forecast HIV/AIDS commodity needs from July 2019 to June 2021. The scope includes:ARVs for all pediatric and adult clients; medicines for prevention of mother-to-child transmission (PMTCT); medicines for pre-exposure prophylaxis (PrEP); medicines for prevention and treatment of opportunistic infection; HIV diagnostic rapid test kits; Early infant diagnosis (EID) pharmaceuticals; Viral load (VL) monitoring and other ART monitoring laboratory pharmaceuticals; medicines for treating sexually transmitted infections (STIs) and condoms for HIV prevention. Forecast results are shown in detail in different sections of this document. Costs of the different subcategories of products are summarized in Table1. Costs include product and procurement and supply management-related costs.